FRI0040 Development and Validation of Clinical Predictors for Inadequate Response to Treat-To-Target Methotrexate Therapy in Newly Diagnosed Ra Patients

doi 10.1136/annrheumdis-2018-eular.3463
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)

British Journal of Dermatology
DermatologyMedicine
2014English

Development and Validation of a Prognostic Multivariable Model to Predict Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2018English

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Clinical Predictors of Response to Anakinra in Patients With Heart Failure

International Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Neuroanatomical Predictors of Response to Donepezil Therapy in Patients With Dementia

Archives of Neurology
2005English

Prs11 - Initiation of Triple Therapy in Newly Diagnosed Copd Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical and Hematological Predictors of Response to First-Line Therapy in Patients With Diffuse Large B-Cell Lymphoma

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2018English

Brodalumab in Patients Who Had Inadequate Response to Ustekinumab

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy